BIA
ABBV icon

BHK Investment Advisors’s AbbVie ABBV Stock Holding History

BHK Investment Advisors’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-3,322
Closed -$242K – 81
2019
Q2 		$242K Buy
3,322
+200
+6% +$15.7K 0.14% 78
2019
Q1 		$252K Buy
+3,122
New +$255K 0.15% 79

Other funds holding ABBV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $23.7B AUM 65.43% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

BHK Investment Advisors's ABBV Position: Q3 2019 in Review

BHK Investment Advisors sold out of AbbVie (ABBV) in Q3 2019, closing a stake of 3,322 shares — an estimated $242K sold.

BHK Investment Advisors first reported a position in ABBV in Q1 2019 and held it in 2 quarters. The position peaked at $252K in Q1 2019. 2,002 funds tracked by Wall St. Rank hold ABBV as of Q3 2019.

  • BHK Investment Advisors reported no remaining AbbVie position as of Q3 2019 after selling out during the quarter.
  • BHK Investment Advisors sold 3,322 AbbVie shares in Q3 2019, an estimated $242K.
  • BHK Investment Advisors first reported a position in AbbVie in Q1 2019 and held it in 2 quarters.
  • BHK Investment Advisors's AbbVie position peaked at $252K in Q1 2019.
  • 2,002 funds tracked by Wall St. Rank held AbbVie as of Q3 2019.

Based on BHK Investment Advisors's 13F filing for Q3 2019, filed 31 Oct 2019.